Successful Flotation Of Gedeon Richter

2 October 1994

The Hungarian State Holding Company, AVRt, has completed the flotation of the country's largest pharmaceutical company, Gedeon Richter, with a private placement in Europe. The roadshow to sell shares in the company targeted Paris, Amsterdam, Frankfurt, Vienna, and London.

Richard Csabay of the AVRt told the Marketletter that 4,413,512 shares were sold on international markets at a price of 1,330 forint ($12.30) per share, and that the Hungarian Credit Bank acquired 37,100 of them.

The AVRt now holds a 62.5% stake in Gedeon Richter; it held an 86.9% stake before the placement. The sale of the shares, which is being combined with a capital increase, should bring Richter around $52.4 million.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight